$EVFM 3 SEC Filings

Filed On	Filing
26 Apr 2023	Form 3: Zhang Yan, Chief Financial Officer Holds 13,000 shares of Common Stock
08 Aug 2022	Form 3: Yip Jenny C., Director No securities owned
07 Jun 2022	Form 3: Atkinson Katherine Cocca, Chief Commercial Officer Holds 16,667 shares of Common Stock
09 Jun 2020	Form 3: Acacia Research Corp, 10% owner Holds 9,139,504 shares of Common Stock, par value $0.0001 per share
26 Feb 2020	Form 3: Rarick Lisa Dale, Director No securities owned
31 Oct 2019	Form 3: Link Fund Solutions Ltd, 10% owner Holds 9,087,206 shares of Common Stock, par value $0.0001 per share
12 Jun 2019	Form 3: Monnet Dominique, Director No securities owned
18 Apr 2019	Form 3: Pdl BIOPHARMA, Inc., 10% owner Holds 6,666,667 shares of Common Stock
18 Jan 2018	Form 3: Rutherford Colin, Director No securities owned
18 Jan 2018	Form 3: Pelletier Saundra L, Director No securities owned
18 Jan 2018	Form 3: O'Brien Anthony Stephen, Director No securities owned
18 Jan 2018	Form 3: Lynch Thomas G, Director No securities owned
18 Jan 2018	Form 3: Hall William Walmsley, Director No securities owned
18 Jan 2018	Form 3: Greer Gillian, Director No securities owned
18 Jan 2018	Form 3: Fitzpatrick Alexander A, General Counsel and Secretary No securities owned
18 Jan 2018	Form 3: File Justin J., Chief Financial Officer No securities owned
18 Jan 2018	Form 3: Culwell Kelly, Chief Medical Officer No securities owned
18 Jan 2018	Form 3: Barrans Russell, Chief Commercial Officer No securities owned
18 Jan 2018	Form 3: Invesco Ltd., 10% owner Holds 7,037,498 shares of Common stock, Par value $0.0001 per share
11 May 2016	Form 3: Feldman Maria, VP Clinical Research & Opera

Comments